CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 90 filers reported holding CYTEK BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $369,078 | -15.3% | 66,862 | +31.0% | 0.00% | – |
Q2 2023 | $435,975 | -36.8% | 51,051 | -32.0% | 0.00% | – |
Q1 2023 | $690,113 | +19.7% | 75,094 | +33.0% | 0.00% | – |
Q4 2022 | $576,426 | -24.3% | 56,457 | +9.3% | 0.00% | – |
Q3 2022 | $761,000 | +23.5% | 51,667 | -10.0% | 0.00% | – |
Q2 2022 | $616,000 | +4.8% | 57,392 | +5.1% | 0.00% | – |
Q1 2022 | $588,000 | +245.9% | 54,584 | +423.9% | 0.00% | – |
Q4 2021 | $170,000 | -19.8% | 10,419 | +5.5% | 0.00% | – |
Q3 2021 | $212,000 | – | 9,876 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Miura Global Management | 2,117,500 | $45,336,000 | 7.03% |
RA Capital Management | 9,607,028 | $205,686,000 | 2.85% |
Octagon Capital Advisors LP | 500,000 | $10,705,000 | 2.64% |
HHLR ADVISORS, LTD. | 8,757,030 | $187,488,000 | 2.45% |
REILLY FINANCIAL ADVISORS, LLC | 79,979 | $10,643,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 328,080 | $7,024,000 | 0.58% |
Orbimed Advisors | 1,923,139 | $41,174,000 | 0.45% |
PURA VIDA INVESTMENTS, LLC | 444,368 | $9,514,000 | 0.29% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 441,518 | $9,453,000 | 0.11% |
FIL Ltd | 2,666,600 | $57,092,000 | 0.06% |